We are analyzing https://link.springer.com/article/10.1007/s00210-025-04315-4.

Title:
Beyond the tumor: the gut microbiome as a key player in immunotherapy efficacy and resistance | Naunyn-Schmiedeberg's Archives of Pharmacology
Description:
Cancer immunotherapy aims to use the immune system of the body for improved therapeutic effects on tumors. Currently, one of the more encouraging interventions under evaluation involves the use of immune checkpoint blockade, which offers longer benefit periods and greater patient tolerance than previous interventions for solid malignancies. Nevertheless, a majority of patients never respond or gradually acquire resistance; hence, a suboptimal effect of the therapy ensues. Resistance to such treatments may arise from tumor-specific factors, host factors, and environmental influences. There is growing evidence that the gut microbiome is an important modulator not only of the efficacy of these treatments but also of toxicities. Current studies are focused on the identification of key microbial profiles from both preclinical and clinical samples associated with immunotherapeutic response and antitumor activities. Elucidation of this complex interaction may provide ways to modulate gut microbial communities to improve patient outcomes. The current review addresses the components responsible for resistance against immune checkpoint inhibitors and highlights the crucial linkage between gut microbiome-immune interactions. We further summarize some recent clinical findings and explore prospective avenues for research in this evolving area of cancer treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

pubmed, article, google, scholar, cas, cancer, central, gut, immune, immunotherapy, microbiota, microbiome, patients, checkpoint, cell, response, oncol, nat, inhibitors, med, immunol, resistance, therapy, res, wang, efficacy, clinical, fecal, york, antipd, bacteria, liu, blockade, rev, melanoma, lung, advanced, yang, front, carcinoma, science, lactobacillus, metastatic, study, human, nivolumab, tumor, effects, effect, clin,

Topics {✒️}

immunoadjuvant-functionalized metal-organic frameworks 2-amino-1-methyl-6-phenyl-1h-imidazo[4 modulating ido1/kyn/ahr axis facilitates anti–pd-l1 efficacy il-17-producing t-helper cells anti-pd-1/pd-l1 immunotherapy month download article/chapter 2-amino-3-methyl-3h-imidazo[4 tumor microenvironment–responsive nanoplatforms low-birth-weight piglets pseudo germ-free rats immune-related adverse events pd-1/pd-l1 pathway small-cell lung cancer phase ii trial anti-pd-1 based immunotherapy bile acid-microbiota crosstalk food mutagen trp-p-2 bifidobacterium strain-specific enhances reduce tumour burden anti-pd-1 refractory patients short-chain fatty acids gut microbiome-immune interactions article naunyn-schmiedeberg' full article pdf antibiotic-disrupted gut microbiome immunotherapy-refractory melanoma patients lactic acid bacteria increasing intestinal development anti-pd-1 inhibitor immune checkpoint inhibitors checkpoint inhibitor immunotherapy butyrate-producing bacterium anti-pd-1 immunotherapy privacy choices/manage cookies randomized clinical trial prevent helicobacter pylori tumor-bearing mice article zhao immune checkpoint blockade fecal microbiota transplant explore prospective avenues pd-1-based immunotherapy gradually acquire resistance cancer prev official immune checkpoints inhibitors advanced renal cell lung cancer treatment anti-pd-1 therapy fecal microbiota transplantation

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Beyond the tumor: the gut microbiome as a key player in immunotherapy efficacy and resistance
         description:Cancer immunotherapy aims to use the immune system of the body for improved therapeutic effects on tumors. Currently, one of the more encouraging interventions under evaluation involves the use of immune checkpoint blockade, which offers longer benefit periods and greater patient tolerance than previous interventions for solid malignancies. Nevertheless, a majority of patients never respond or gradually acquire resistance; hence, a suboptimal effect of the therapy ensues. Resistance to such treatments may arise from tumor-specific factors, host factors, and environmental influences. There is growing evidence that the gut microbiome is an important modulator not only of the efficacy of these treatments but also of toxicities. Current studies are focused on the identification of key microbial profiles from both preclinical and clinical samples associated with immunotherapeutic response and antitumor activities. Elucidation of this complex interaction may provide ways to modulate gut microbial communities to improve patient outcomes. The current review addresses the components responsible for resistance against immune checkpoint inhibitors and highlights the crucial linkage between gut microbiome-immune interactions. We further summarize some recent clinical findings and explore prospective avenues for research in this evolving area of cancer treatment.
         datePublished:2025-06-03T00:00:00Z
         dateModified:2025-06-03T00:00:00Z
         pageStart:1
         pageEnd:21
         sameAs:https://doi.org/10.1007/s00210-025-04315-4
         keywords:
            Immunotherapy
            Immune checkpoint inhibitors
            Gut microbiome
            Therapeutic resistance
            Pharmacology/Toxicology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04315-4/MediaObjects/210_2025_4315_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04315-4/MediaObjects/210_2025_4315_Fig2_HTML.png
         isPartOf:
            name:Naunyn-Schmiedeberg's Archives of Pharmacology
            issn:
               1432-1912
               0028-1298
            type:
               Periodical
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yuemei Zhao
               affiliation:
                     name:Shaoxing People’s Hospital
                     address:
                        name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Weidong Liu
               affiliation:
                     name:Shaoxing People’s Hospital
                     address:
                        name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuehong Hu
               affiliation:
                     name:Shaoxing People’s Hospital
                     address:
                        name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Beyond the tumor: the gut microbiome as a key player in immunotherapy efficacy and resistance
      description:Cancer immunotherapy aims to use the immune system of the body for improved therapeutic effects on tumors. Currently, one of the more encouraging interventions under evaluation involves the use of immune checkpoint blockade, which offers longer benefit periods and greater patient tolerance than previous interventions for solid malignancies. Nevertheless, a majority of patients never respond or gradually acquire resistance; hence, a suboptimal effect of the therapy ensues. Resistance to such treatments may arise from tumor-specific factors, host factors, and environmental influences. There is growing evidence that the gut microbiome is an important modulator not only of the efficacy of these treatments but also of toxicities. Current studies are focused on the identification of key microbial profiles from both preclinical and clinical samples associated with immunotherapeutic response and antitumor activities. Elucidation of this complex interaction may provide ways to modulate gut microbial communities to improve patient outcomes. The current review addresses the components responsible for resistance against immune checkpoint inhibitors and highlights the crucial linkage between gut microbiome-immune interactions. We further summarize some recent clinical findings and explore prospective avenues for research in this evolving area of cancer treatment.
      datePublished:2025-06-03T00:00:00Z
      dateModified:2025-06-03T00:00:00Z
      pageStart:1
      pageEnd:21
      sameAs:https://doi.org/10.1007/s00210-025-04315-4
      keywords:
         Immunotherapy
         Immune checkpoint inhibitors
         Gut microbiome
         Therapeutic resistance
         Pharmacology/Toxicology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04315-4/MediaObjects/210_2025_4315_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-04315-4/MediaObjects/210_2025_4315_Fig2_HTML.png
      isPartOf:
         name:Naunyn-Schmiedeberg's Archives of Pharmacology
         issn:
            1432-1912
            0028-1298
         type:
            Periodical
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yuemei Zhao
            affiliation:
                  name:Shaoxing People’s Hospital
                  address:
                     name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Weidong Liu
            affiliation:
                  name:Shaoxing People’s Hospital
                  address:
                     name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuehong Hu
            affiliation:
                  name:Shaoxing People’s Hospital
                  address:
                     name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical"]:
      name:Naunyn-Schmiedeberg's Archives of Pharmacology
      issn:
         1432-1912
         0028-1298
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shaoxing People’s Hospital
      address:
         name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
         type:PostalAddress
      name:Shaoxing People’s Hospital
      address:
         name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
         type:PostalAddress
      name:Shaoxing People’s Hospital
      address:
         name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yuemei Zhao
      affiliation:
            name:Shaoxing People’s Hospital
            address:
               name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
               type:PostalAddress
            type:Organization
      name:Weidong Liu
      affiliation:
            name:Shaoxing People’s Hospital
            address:
               name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
               type:PostalAddress
            type:Organization
      name:Yuehong Hu
      affiliation:
            name:Shaoxing People’s Hospital
            address:
               name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
      name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
      name:Department of Surgery and Critical Care Medicine, Shaoxing People’s Hospital, ShaoxingShaoxing City, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(434)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.63s.

LINK . SPRINGER . COM {}